These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17975146)

  • 1. Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.
    Ugurel S; Houben R; Schrama D; Voigt H; Zapatka M; Schadendorf D; Bröcker EB; Becker JC
    Clin Cancer Res; 2007 Nov; 13(21):6344-50. PubMed ID: 17975146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
    Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.
    Salti GI; Manougian T; Farolan M; Shilkaitis A; Majumdar D; Das Gupta TK
    Cancer Res; 2000 Sep; 60(18):5012-6. PubMed ID: 11016620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Kusić Z
    Croat Med J; 2004 Apr; 45(2):142-8. PubMed ID: 15103749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
    Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
    Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of microphthalmia transcription factor (Mitf) by forskolin and stimulation of melanin release in UISO-Mel-6 cells.
    Lekmine F; Salti GI
    J Surg Res; 2008 Sep; 149(1):27-30. PubMed ID: 18028952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
    Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
    Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.
    Selzer E; Wacheck V; Lucas T; Heere-Ress E; Wu M; Weilbaecher KN; Schlegel W; Valent P; Wrba F; Pehamberger H; Fisher D; Jansen B
    Cancer Res; 2002 Apr; 62(7):2098-103. PubMed ID: 11929831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.
    Bemis LT; Chen R; Amato CM; Classen EH; Robinson SE; Coffey DG; Erickson PF; Shellman YG; Robinson WA
    Cancer Res; 2008 Mar; 68(5):1362-8. PubMed ID: 18316599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
    Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
    J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel MITF targets identified using a two-step DNA microarray strategy.
    Hoek KS; Schlegel NC; Eichhoff OM; Widmer DS; Praetorius C; Einarsson SO; Valgeirsdottir S; Bergsteinsdottir K; Schepsky A; Dummer R; Steingrimsson E
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):665-76. PubMed ID: 19067971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Lineage addiction" in human cancer: lessons from integrated genomics.
    Garraway LA; Weir BA; Zhao X; Widlund H; Beroukhim R; Berger A; Rimm D; Rubin MA; Fisher DE; Meyerson ML; Sellers WR
    Cold Spring Harb Symp Quant Biol; 2005; 70():25-34. PubMed ID: 16869735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
    Quaglino P; Osella-Abate S; Cappello N; Ortoncelli M; Nardò T; Fierro MT; Cavallo F; Savoia P; Bernengo MG
    Melanoma Res; 2007 Apr; 17(2):75-82. PubMed ID: 17496782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
    Primot A; Mogha A; Corre S; Roberts K; Debbache J; Adamski H; Dreno B; Khammari A; Lesimple T; Mereau A; Goding CR; Galibert MD
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):93-102. PubMed ID: 19895547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf.
    Nakai N; Kishida T; Shin-Ya M; Imanishi J; Ueda Y; Kishimoto S; Mazda O
    Gene Ther; 2007 Feb; 14(4):357-65. PubMed ID: 17024102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microphthalmia transcription factor: a specific marker for malignant melanoma.
    Vachtenheim J; Borovanský J
    Prague Med Rep; 2004; 105(3):318-24. PubMed ID: 15782558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.
    Giuliano S; Cheli Y; Ohanna M; Bonet C; Beuret L; Bille K; Loubat A; Hofman V; Hofman P; Ponzio G; Bahadoran P; Ballotti R; Bertolotto C
    Cancer Res; 2010 May; 70(9):3813-22. PubMed ID: 20388797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
    Garraway LA; Widlund HR; Rubin MA; Getz G; Berger AJ; Ramaswamy S; Beroukhim R; Milner DA; Granter SR; Du J; Lee C; Wagner SN; Li C; Golub TR; Rimm DL; Meyerson ML; Fisher DE; Sellers WR
    Nature; 2005 Jul; 436(7047):117-22. PubMed ID: 16001072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUMA expression is significantly reduced in human cutaneous melanomas.
    Karst AM; Dai DL; Martinka M; Li G
    Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.